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Abstract: Post-weaning diarrhoea (PWD) due to enterotoxigenic Escherichia coli (ETEC) is an
economically important disease in pig production worldwide. Although antibiotics have contributed
significantly to mitigate the economic losses caused by PWD, there is major concern over the increased
incidence of antimicrobial resistance among bacteria isolated from pigs. Consequently, suitable
alternatives that are safe and effective are urgently required. Many naturally occurring compounds,
including the antimicrobial peptide nisin and a number of plant essential oils, have been widely
studied and are reported to be effective as antimicrobial agents against pathogenic microorganisms.
Here, we evaluate the potential of nisin in combination with the essential oil cinnamaldehyde
and ethylenediaminetetraacetic acid (EDTA) to control the growth of E. coli strains of swine origin
including two characterized as ETEC. The results reveal that the use of nisin (10 µM) with low
concentrations of trans-cinnamaldehyde (125 µg/mL) and EDTA (0.25–2%) resulted in extended lag
phases of growth compared to when either antimicrobial is used alone. Further analysis through kill
curves revealed that an approximate 1-log reduction in E. coli cell counts was observed against the
majority of targets tested following 3 h incubation. These results highlight the potential benefits of
combining the natural antimicrobial nisin with trans-cinnamaldehyde and EDTA as a new approach
for the inhibition of E. coli strains of swine origin.
Keywords: antimicrobial resistance; antibiotics; antimicrobial peptide; enterotoxigenic E. coli; nisin;
bacteriocin; essential oil; cinnamaldehyde; EDTA
1. Introduction
Post-weaning diarrhea (PWD) is one of the most life-threatening diseases in the swine industry
worldwide. It is commonly associated with the proliferation of enterotoxigenic Escherichia coli (ETEC)
in the pig intestine resulting in mortality, dehydration, weight loss and retarded growth [1]. Current
control strategies frequently involve polymyxins, macrolides and fluoroquinolones, antibiotics that
are also critically important in human medicine [2]. However, the routine use of in-feed antibiotics
was banned in the European Union (EU) in 2006 (Regulation EC/1831/2003), although their use is
still permitted under veterinary prescription as the need arises. Moreover, in recent times the use of
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antimicrobials in food production animals has come under considerable scrutiny, given that recent
genomic and metagenomic studies in humans, animals and in the environment have brought to light
the existence of a reservoir of antibiotic resistance genes that could be mobilized and transferred from
these sources to human pathogens [3–5]. In addition, the use of zinc oxide (ZnO) at pharmacological
concentrations (i.e., concentrations in excess of normal dietary requirements) will no longer be a
therapeutic option for the prevention and control of PWD and bowel oedema in young pigs in the EU.
This follows the recent ruling by the Committee for Medicinal Products for Veterinary Use (CVMP)
to ban its use. Consequently, there is increasing emphasis on practices to reduce antibiotic usage in
animal husbandry by promoting prudent use initiatives, as well as exploring the implementation of
potential alternatives for the use of antibiotics and zinc oxide in livestock production.
One group of antimicrobials that have been at the forefront of alternative antibiotic research for
decades are the lantibiotic class of bacteriocins (bacterially produced, small, heat-stable peptides that
are active against other bacteria). The best known lantibiotic is nisin A, a 34-amino acid polycyclic
peptide that exhibits antibacterial activity against a wide range of clinical and food-borne pathogens
and is widely used as a natural food biopreservative [6]. Although nisin is not currently used
for medical applications, it has realized commercial applications in the veterinary industry for the
prevention/treatment of bovine mastitis [7,8]. It functions by a distinctive dual mode of action
involving binding to lipid II, an essential precursor of the bacterial cell wall, followed by insertion
into the membrane of the target cell to form a pore [9–11]. As a consequence of these two distinct and
cooperative mechanisms, no significant resistance to nisin A has been observed despite its widespread
use over several decades by the food industry [12]. Consequently, lantibiotics such as nisin A possess
enormous potential for therapeutic applications, not only as alternatives but also as synergists with
other antimicrobials. For example, aromatic plant oils have been widely investigated due to their
antimicrobial activities and numerous studies have demonstrated the synergistic activities of nisin
and essential oil combinations including thymol [13], carvacrol [14,15] and cinnamaldehyde [16],
amongst others. Similarly, the activity of nisin can be enhanced through the addition of chelating agents
such as ethylenediaminetetraacetic acid (EDTA) [17,18]. Recently, Al Atya and coworkers demonstrated
the effectiveness of nisin in combination with colistin towards E. coli strains of swine origin [19].
Importantly, the combination proved effective against both planktonic and biofilm cultures of E. coli
strains exhibiting a colistin-resistance phenotype, validating the potential of such strategies to reduce
the effective dose required for these antibiotics to help prevent or delay the further spread of resistance.
Indeed, such approaches are all the more urgent given the directive that all EU Member States are
required to achieve a reduction of approximately 65% in the current sales of colistin for veterinary use
at an EU level by 2020 (https://www.cdc.gov/drugresistance/tatfar/tatfar-recomendations.html).
However, if the use of colistin and other critical antibiotics is to be diminished or replaced in animal
husbandry, suitable alternatives that are safe and efficient must be found.
Here we assess the efficacy of nisin in combination with a variety of essential oils and EDTA,
and establish that a nisin + EDTA + cinnamaldehyde combination exhibits significantly greater
anti-E coli activity compared to the use of either antimicrobial alone.
2. Results
2.1. Bacterial Susceptibility to Antimicrobial Compounds
Minimum inhibitory concentration assays (MICs) with purified nisin A peptide and the essential
oils thymol, carvacrol and trans-cinnamaldehyde were determined against E. coli targets of pig
origin, including two characterized as ETEC (K88F4 and F18ab) in order to ascertain appropriate
concentrations for combinatorial assays. Additionally, MIC assays were also carried out to establish
the relative sensitivity or resistance to a range of antibiotics including penicillin, erythromycin,
chloramphenicol, tetracycline, cefuroxime, ceftazidime, colistin and polymyxin B. Activity against the
target strains required a relatively high concentration of nisin (200 µg/mL). This value was in agreement
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with data obtained by Naghmouchi and co-workers against a panel of Gram-negative strains [20]
and, yet again, highlights the relative resistance of Gram-negative bacteria to nisin compared to
Gram-positive strains which can have MICs in the nanomolar (nM) range. The majority of the E. coli
targets were resistant to erythromycin, tetracycline and penicillin, with the exception of E. coli F2S2,
which remained sensitive to chloramphenicol and tetracycline (Table 1) and were overall in agreement
with previous studies with E. coli strains of swine origin [19,21]. Colistin and polymyxin B exhibited
almost identical activity against 4 of 5 of the target strains and were in close agreement with previously
established figures against sensitive strains of E. coli [19,22]. The exception was the ETEC F18ab
strain which exhibited an MIC of 25 µg/mL for both polymyxin and colistin (Table 1), indicative
of resistance to these antimicrobials. Furthermore, all of the target strains remained sensitive to the
cephalosporin antibiotics ceftazidime, cefuroxime and cefradine, while resistance to cefoxitin was
observed for all strains. The susceptibility of the bacterial strains to the essential oils thymol, carvacrol
and trans-cinnamaldehyde was also assessed in order to ascertain appropriate concentrations for
combinatorial assays. Cinnamaldehyde proved to be the most active of the essential oils with an
inhibitory concentration of 1250 µg mL−1 which was within the 400–1322 µg mL−1 range established
by previous studies [23].
Table 1. Minimum inhibitory concentration determinations of nisin A, and the essential oils thymol,
carvacrol and trans-cinnamaldehyde against E. coli strains of swine origin. ‡ denotes enterotoxigenic
Escherichia coli (ETEC) strains. Results are expressed as the mean of triplicate assays.
Antibiotic
E. coli Strain
F150F3 F2S2 K88F4 ‡ F3P3 F18ab ‡
Chloramphenicol >50 12.5 >50 >50 12.5
Tetracycline >50 1.56 50 25 50
Penicillin G >50 25 25 25 12.5
Streptomycin >50 25 >50 12.5 1.56
Cefoxitin >50 >50 >50 >50 >50
Erythromycin >50 >50 >50 >50 50
Lincomycin >50 >50 >50 >50 >50
Ceftazidine <0.4 <0.4 <0.4 <0.4 <0.4
Cefuroxime 6.25 3.12 6.25 6.25 6.25
Cefradine 25 12.5 25 25 12.5
Cefsulodin >50 50 50 50 50
Colistin 0.39 0.39 <0.2 <0.2 25
Polymyxin B 0.39 0.39 <0.2 <0.2 25
Carvacrol >1250 >1250 >1250 >1250 >1250
Cinnamaldehyde 1250 1250 1250 >1250 1250
Thymol >1250 >1250 >1250 >1250 >1250
Nisin 200 200 200 200 200
2.2. Growth Curve-Based Comparisons of the Activity of Nisin A and Natural Antimicrobial Combinations
Having established the MIC values for nisin A and a range of essential oils against the panel of
E. coli strains, growth curves were performed in order to reveal the impact of sub-lethal concentrations
of nisin A, cinnamaldehyde and EDTA (alone and in combination) on bacterial growth. The final
concentration of nisin or cinnamaldehyde used for each organism was a fraction of the previously
determined MIC value (i.e., 1/10×, 1/6×, 1/4×, etc.) and combinations thereof. Initial growth curves
were carried out with EDTA to establish levels that were marginally inhibitory compared to a control
strain in the absence of EDTA for each of the strains. Nisin at 1/6× MIC (33 µg/mL) had little or no
impact on the growth of the targets E. coli K88F4 (Figure 1A), E. coli F3P3 (Figure 1B) or E. coli F2S2
(Figure 1C), affirming the relatively poor activity of nisin against Gram-negative bacteria. Similarly,
a slight lag in growth was observed for both EDTA and cinnamaldehyde (at 1/10× MIC; 125 µg/mL)
when compared to the untreated control (Figure 1). However, pronounced inhibitory effects were
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recorded when nisin was used in combination with cinnamaldehyde and EDTA against E. coli K88F4
(Figure 1A), E. coli F3P3 (Figure 1B), E. coli F2S2 (Figure 1C), as observed by the exceptionally extended
lag phase in all cases compared to the untreated control. Notably, the combination also proved effective
against the colistin and polymyxin B-resistant ETEC F18ab strain (Figure 1D).Antibiotics 2017, 6, 35 4 of 10 
 
Figure 1. Growth curve analysis of (A) E. coli K88F4 in the presence of 1/6× minimum inhibitory 
concentration (MIC; 33 μg/mL) nisin A (blue inverted triangle), 1/10× MIC (125 μg/mL) 
cinnamaldehyde (orange triangle), ethylenediaminetetraacetic acid (EDTA) 1.0% (purple circle) in 
combination (red diamond) and untreated control (green circle), (B) E. coli F3P3 in the presence of 
1/6× MIC (33 μg/mL) nisin A (blue inverted triangle), 1/10× MIC (125 μg/mL) cinnamaldehyde (orange 
triangle), EDTA 2% (purple circle), in combination (red diamond) and untreated control (green circle), 
(C) E. coli F2S2 in the presence of 1/6× MIC (33 μg/mL) nisin A (blue inverted triangle), 1/10× MIC (125 
μg/mL) cinnamaldehyde (orange triangle), EDTA 1% (purple circle), in combination (red diamond) 
and untreated control (green circle) and (D) E. coli F18ab in the presence of 1/6× MIC (33 μg/mL) nisin 
A (blue inverted triangle), 1/10× MIC (125 μg/mL) cinnamaldehyde (orange triangle), EDTA 0.25% 
(purple circle), in combination (red diamond) and untreated control (green circle). ‡ denotes ETEC 
strains. 
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Following on from the data established by growth curves, the bactericidal activity of nisin in 
combination with cinnamaldehyde and EDTA against the target E. coli was investigated utilising kill 
assays within a defined period of time (3 h). E. coli F2S2, E. coli K88F4, E. coli F3P3 and E. coli F18ab 
at a concentration of 1× 107 cfu were exposed to nisin (33 μg/mL), cinnamaldehyde (125 μg/mL) and 
EDTA (1%, 2%, 2%, 0.25%, respectively) at 37 °C for 3 h. 
In general, an approximate 1-log reduction in E. coli counts was observed for the antimicrobial 
combination compared to the initial inoculum (Figure 2). When compared to the untreated control, a 
2-log differential in cell numbers was observed between the antimicrobial combination and the 
control in each case for E. coli K88F4, (p < 0.046), E. coli F3P3 (p < 0.043) and E. coli F2S2 (p < 0.005). The 
exception was E. coli F18ab whereby cell numbers remained static (2.9 × 107 cfu/mL; Figure 2) 
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Figure 1. Growth curve analysis of (A) E. coli K 4 in the pres nce of 1/6× i imum inhibitory
concentration (MIC; 33 µg/mL) nisin A (blue inverted triangle), 1/10× MIC (125 µg/mL)
cinnamaldehyde (orange triangle), ethylenediaminetetraacetic acid (EDTA) 1.0% (purple circle) in
combination (red diamond) and untreated control (green circle), (B) E. coli F3P3 in the presence of
1/6× MIC (33µg/mL) nisin A (blue inverted tri ngle), 1/10×MIC (125µg/mL) cinnamaldehyde (orange
triangle), EDTA 2% (purple circle), in combination (red diamond) and untreated control (green circle),
(C) E. coli F2S2 in the presence of 1/6× MIC (33 µg/mL) nisin A (blue inverted triangle), 1/10× MIC
(125 µg/mL) cinnamaldehyde (orange triangle), EDTA 1% (purple circle), in combination (red diamond)
and untreated control (green circle) an (D) E. coli F18ab in the presence of 1/6× MIC (33 µg/mL) nisin
A (blue inverted triangle), 1/10× MIC (125 µg/mL) cinnamaldehyde (orange triangle), EDTA 0.25%
(purple circle), in combination (red diamond) and untreated control (green circle). ‡ denotes ETEC strains.
2.3. Kill Assay Determination of the Activity of Nisin A and Natural Antimicrobial Combinations
Following on from the data established by growth curves, the bactericidal activity of nisin in
combination with cinnamaldehyde and EDTA against the target E. coli was investigated utilising kill
assays within a defined period of time (3 h). E. coli F2S2, E. coli K88F4, E. coli F3P3 and E. coli F18ab at
a concentration of 1 × 107 cfu w re exposed to n sin (33 µg/mL), cinnamaldehyde (125 µg/mL) and
EDTA (1%, 2%, 2%, 0.25%, respectively) at 37 ◦C for 3 h.
In general, an approximate 1-log reduction in E. coli counts was observed for the antimicrobial
combination compared to the initial inoculum (Figure 2). Whe compared to the untreated control,
a 2-log differential in cell numbers was observed between the antimicrobial combination and the
control in each case for E. coli K88F4, (p < 0.046), E. coli F3P3 (p < 0.043) and E. coli F2S2 (p < 0.005).
The exception was E. coli F18ab whereby cell numbers remained static (2.9 × 107 cfu/mL; Figure 2)
following 3 h of incubation. In contrast, the untreated control had increased to 2.3 × 108 cfu/mL.
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Gram-negative bacteria (due to the outer membrane of the Gram-negative cell wall that acts as a 
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Figure 2. Kill effect of nisin in combination with cinnamaldehyde and EDTA against E. coli strains
of swine origin. Kill assay performed over a defined 3 h period with E. coli K88F4 in the presence
of nisin (33 µg/mL) + cinnamaldehyde (125 µg/mL) + EDTA (1%) and untreated control (Green),
E. coli F3P3 in the presence of nisin (33 µg/mL) + cinnamaldehyde (125 µg/mL) + EDTA (2%) (Red)
and untreated control (Green), E. coli F2S2 in the presence of nisin (33 µg/mL) + cinnamaldehyde
(125 µg/mL) + EDTA (1%) EDTA 2% (Red) and untreated control (Green), E. coli F18ab in the presence
of nisin (33 µg/mL) + cinnamaldehyde (125 µg/mL) + EDTA (0.25%) (Red) and untreated control
(Green). Asterisks rating of * indicates statistically significant differences between groups (p ≤ 0.05).
‡ denotes ETEC strains.
3. Discussion
Post-weaning diarrhea is an economically important enteric disease in pigs resulting in significant
financial losses. It is commonly associated with the proliferation of ETEC, a pathotype characterized
by the production of enterotoxins and adhesins, both essential for disease development [24] that act on
the intestinal epithelium of pigs. Alarmingly, critically important antibiotics such as fluoroquinolones,
aminoglycosides and polymyxins are sold in vast quantities for use in pigs during the post-weaning
period in many countries worldwide [25]. However, the emergence of bacterial resistance to these
antibiotics has dictated that effective and sustainable alternative approaches to tackling microbial
disease in both humans and livestock must be identified. Here, we set out to examine for the
first time the ability of nisin, when used in conjunction with a selection of natural antimicrobials
including essential oils, to control several E. coli strains of swine origin, including two characterized as
ETEC, with the ultimate aim of identifying superior antimicrobial combinations. Following MIC
determinations and growth curve analysis in the presence of nisin + cinnamaldehyde + EDTA
combinations, substantial enhanced inhibitory relationships were observed. The results reveal that
sub-inhibitory levels of nisin (1/6× MIC) and cinnamaldehyde (1/10× MIC) supplemented with
EDTA (0.25–2%) can effectively control the growth of E. coli numbers in laboratory media. In contrast,
nisin was ineffective against the E. coli targets when used independently. Indeed, considerable
work has been conducted to enhance the poor antibacterial activity of nisin toward Gram-negative
bacteria (due to the outer membrane of the Gram-negative cell wall that acts as a physical barrier,
obstructing access of the peptides to the cytoplasmic membrane). Such strategies have included
destabilization of the outer membrane by combining with essential oils that contain aldehydes, terpenes
and phenolic compounds [26,27]. Other strategies have involved nisin and chelating agents such as
EDTA, which acts by removing Mg2+ and Ca2+ ions essential for stabilizing the lipopolysaccharide
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(LPS) outer membrane of Gram-negative bacteria [18,28]. Our investigations also highlight the
enhanced potency of nisin when combined with trans-cinnamaldehyde and EDTA, implying that
combinations of two or more antimicrobials, which affect different targets, exhibit great potential as a
new approach against pathogenic-resistant bacteria. Moreover, all the aforementioned antimicrobials
are classified as GRAS (Generally Recognized as Safe) by the FDA (Food and Drug Administration).
Notably, a product containing the sodium salt of EDTA (Na2EDTA), a tannin-rich extract of Castanea
sativa, thyme oil and oregano oil was recently assessed by EFSA for use with pigs at a recommended
dose of 1000 mg/kg feed to reduce the incidence of dysentery caused by Brachyspira hyodysenteriae
and so improve performance [29]. Furthermore, the European Food Safety Authority (EFSA) panel
concluded that the additive was considered safe for pigs at the recommended dose of 1000 mg/kg
feed of which Na2EDTA constituted 24% (equivalent to 240 mg). None of the active constituents raised
safety concerns for consumers when considered individually and at the concentrations delivered to
feed using the recommended dose. Indeed, animal feeding studies to investigate EDTA toxicity have
established an LD50 value of 2000–2200 mg/kg bw for rats, while a no observed adverse effect level
(NOAEL) of 500 mg/kg bw per day for Na2EDTA and Na3EDTA was determined from a 90-day
study in rats and in a long-term (2-year) study in rats and mice [30]. However, rats fed 1%, 5% or 10%
disodium salt of EDTA for 90 days had significantly lower food consumption and weight gain than
controls [31]. Although the concentrations of EDTA used in this study (0.25–2%) exceed the maximum
permitted dose (by 10–100 fold), reductions in EDTA concentration may be achieved through Response
Surface Methodology which has been used very effectively to analyze, predict and model systems
that require optimization of multiple factors and has been used previously for nisin, EDTA and pH
combinations [32]. Alternatively, other chelators could be investigated as well as the use of other
natural antimicrobial compounds such as organic acids, which have been shown to control PWD
and enhance growth performance in pigs [33–35] and have been shown to act synergistically with
nisin [36].
Several studies have investigated the ability of essential oil compounds to control the proliferation
of pathogenic bacteria, as well as contribute to better gut health in pigs and potentially replace the
use of antibiotic growth promoters which have been prohibited in the European Union since 2006 [37].
For example, Li and co-workers demonstrated that the addition of encapsulated essential oils (thymol
and cinnamaldehyde) improved feed intake and growth rate, reduced the incidence of diarrhoea and
resulted in a positive modulation of microbial populations measured in the faeces, with a reduction
of E. coli and an increase of Lactobacillus counts [38]. Similarly, addition of an essential oil to weaner
pig diets showed evidence of a reduction in Salmonella faecal shedding and numbers of coliforms and
Salmonella in cecal digesta [39], and administration of an encapsulated blend of formic acid, citric acid
and essential oils [40] to finishing pigs for 28 days prior to slaughter reduced Salmonella seroprevalence
and demonstrated potential for the prevention of Salmonella shedding. In addition, the inclusion
of cinnamaldehyde with blended organic acids and a permeabilising agent in the diets of weaned
pigs experimentally infected with ETEC was found to decrease faecal E. coli concentrations, with no
effect on the concentration of faecal lactobacilli [41]. While there is a paucity of studies involving
nisin and pigs, the benefits of incorporating nisin into the diets of poultry [42] and rabbits [43] have
been established.
In this study, we have provided proof of concept that the natural antimicrobial peptide nisin in
combination with natural plant extracts such as trans-cinnamaldehyde could expand the spectrum
of useful therapeutics and form a novel strategy in the control of ETEC infection in post-weaning
pigs. However, in vivo studies along with genomic characterization and transcriptomic and proteomic
profiling of the gut microbiota will be necessary to validate the antimicrobial efficacy and safety of
these antimicrobial combinations for use in pigs.
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4. Materials and Methods
4.1. Bacterial Strains and Growth Conditions
Lactococcus lactis NZ9700 (a nisin A producing strain used for peptide purification) was grown in
M17 broth supplemented with 0.5% glucose (GM17) or GM17 agar at 30 ◦C. E. coli strains F150F3, F2S2,
F3P3, K88F4 and F18ab were grown in Luria–Bertani (LB) broth (5 g/L yeast extract [Oxoid, Hampshire,
UK], 10 g/L tryptone [Oxoid] and 10 g/L NaCl [Merck, Nottingham UK]), incubated overnight at 37 ◦C
and shaken at 170 rpm. E. coli strains F150F3, F2S2 and F3P3 were isolates from pooled faecal samples
from across different pig production stages and the designation F refers to Farm. Enterotoxigenic E. coli
(ETEC) strains K88F4 and F18ab were PCR-positive for F4 and F18 adhesins, respectively. E. coli K88F4
was determined to be serotype O147 and positive for STb, LT and EAST1 toxins but negative for STa.
E. coli F18ab was determined to be serotype O141 and negative for STa, STb, EAST1 and LT toxins.
4.2. Minimum Inhibitory Concentration Assays
Minimum inhibitory concentration (MIC) determinations were carried out in triplicate in 96-well
microtitre plates (Sarstedt, Rheinbach, Germany) as described previously [36,37]. Briefly, target strains
were grown overnight in the appropriate conditions and medium, subcultured into fresh broth
and allowed to grow to an OD600 of ~0.5 and diluted to a final concentration of 105 cfu mL−1 in a
volume of 0.2 mL. Chloramphenicol, penicillin G, erythromycin, tetracycline, colistin and polymyxin
B (Sigma, Steinheim, Germany) were resuspended in LB broth to a stock concentration of 128 or
256 µg/mL. The antibiotics were adjusted to 16, 32, 64 or 128 µg/mL starting concentration and 2-fold
serial dilutions of each compound were made in 96-well plates for a total of 12 dilutions. The MIC
assays of essential oils were carried out as above but were diluted to a starting concentration of
2 mg/mL for serial dilution of thymol, carvacrol and trans-cinnamaldehyde. Purified nisin was
adjusted to a 120 µM (400 µg/mL) starting concentration and 2-fold serial dilutions were carried out.
The target strain was then added and after incubation for 16 h at 37 ◦C, the MIC was read as the lowest
concentration causing inhibition of visible growth.
4.3. Nisin Purification
Nisin was purified according to previously described protocols [44–46]. The purified nisin peptide
was subjected to MALDI-ToF Mass Spectrometric analysis to confirm purity before use.
4.4. Growth Curve Experiments
For growth experiments, overnight cultures were transferred (107 cfu mL−1 in a volume of 1.0 mL)
into LB supplemented with the relevant concentration of nisin A and antibiotic/peptide or essential
oil/peptide/EDTA combinations, and subsequently 0.2 mL was transferred to 96-well microtitre plates
(Sarstedt). Cell growth was measured spectrophotometrically over 24 h or 48 h periods by using a
SpectraMax M3 spectrophotometer (Molecular Devices, Sunnyvale, CA, USA).
4.5. Kill Assay Analysis
For kill assays, overnight cultures of target strains were transferred into LB broth (1 mL)
containing nisin-purified peptide in combination with cinnamaldehyde and EDTA at the appropriate
concentration. Samples were incubated for 3 h at 37 ◦C before serial dilution in Ringers solution
followed by enumeration on LB agar plates. All experiments were carried out in triplicate.
4.6. Statistical Analysis
E. coli data were checked for normality and homogeneity of variances using the Shapiro–Wilk
test and Levene’s test, respectively. All comparisons were based on the mean ± standard deviation.
Parametric data were analyzed using independent t-tests. Non-parametric data were analyzed by
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the Mann–Whitney U-test. All tests were performed using a 5% level of significance. All statistically
significant results are complimented with the corresponding effect size using Cohen’s d classification.
5. Conclusions
The increasing pressure on the livestock industry to halt the use of in-feed antibiotics has initiated
new research to find safe and efficient alternatives. The combination of nisin peptides, essential oils
such as cinnamaldehyde, and EDTA could pave the way for new treatment concepts when it comes to
PWD, in particular towards Gram-negative bacteria including drug-resistant ETEC.
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